Effects of genetic polymorphisms on methotrexate levels and toxicity in Chinese patients with acute lymphoblastic leukemia

被引:7
作者
Hao, Qishan [1 ]
Song, Yang [1 ]
Fang, Qiuyun [1 ]
Lin, Yani [2 ]
Chen, Long [2 ]
Wang, Xiaodan [1 ]
Zhang, Ping [1 ]
Wang, Zhe [1 ]
Gong, Xiaoyuan [1 ]
Liu, Kaiqi [1 ]
Li, Qinghua [1 ]
Tian, Zheng [1 ]
Wang, Min [1 ]
Wang, Jianxiang [1 ]
Mi, Yingchang [1 ,3 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, Tianjin, Peoples R China
[2] SINO US Diagnost Lab, Tianjin, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Haihe Lab Cell Ecosyst, State Key Lab Expt Hematol,Natl Clin Res Ctr Blood, 288 Nanjing Rd, Tianjin, Peoples R China
来源
BLOOD SCIENCE | 2023年 / 5卷 / 01期
关键词
Acute lymphoblastic leukemia; Concentration; Methotrexate; Polymorphism; Toxicity; HIGH-DOSE METHOTREXATE; ABCC2; POLYMORPHISMS; PLASMA METHOTREXATE; CHILDREN; THERAPY; IMPACT;
D O I
10.1097/BS9.0000000000000142
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methotrexate (MTX) has an antitumor effect when used for the treatment of acute lymphoblastic leukemia (ALL). This study aims at evaluating the associations between 14 polymorphisms of six genes involved in MTX metabolism with serum MTX concentration and toxicity accompanying high-dose MTX. Polymorphisms in 183 Chinese patients with ALL were analyzed using TaqMan single nucleotide polymorphism genotyping assay. The serum MTX concentration was determined using homogeneous enzyme immunoassay. MTX-related toxicities were also evaluated. Renal toxicity was significantly associated with higher serum MTX concentrations at 24, 48, and 72 hours, and MTX elimination delay (P = 0.001, P < 0.001, P < 0.001, and P < 0.001, respectively), whereas SLCO1B1 rs4149056 was associated with serum MTX concentrations at 48 and 72 hours, and MTX elimination delay in candidate polymorphisms (P = 0.014, P = 0.019, and P = 0.007, respectively). SLC19A1 rs2838958 and rs3788200 were associated with serum MTX concentrations at 24 hours (P = 0.016, P = 0.043, respectively). MTRR rs1801394 was associated with serum MTX concentrations at 72 hours (P = 0.045). Neutropenia was related to SLC19A1 rs4149056 (odds ratio [OR]: 3.172, 95% confidence interval [CI]: 1.310-7.681, P = 0.011). Hepatotoxicity was associated with ABCC2 rs2273697 (OR: 3.494, 95% CI: 1.236-9.873, P = 0.018) and MTRR rs1801394 (OR: 0.231, 95% CI: 0.084-0.632, P = 0.004). Polymorphisms of SLCO1B1, SLC19A1, ABCC2, and MTRR genes help predict higher risk of increased MTX levels or MTX-related toxicities in adult ALL patients.
引用
收藏
页码:32 / 38
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 2017, Common terminology criteria for adverse events (CTCAE) version 5
[2]   Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers [J].
Brown, Philip M. ;
Pratt, Arthur G. ;
Isaacs, John D. .
NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (12) :731-742
[3]   Influence of plasma methotrexate level and MTHFR genotype in Korean paediatric patients with acute lymphoblastic leukaemia [J].
Chae, Hyojin ;
Kim, Myungshin ;
Choi, Sun Hee ;
Kim, Seong-koo ;
Lee, Jae-Wook ;
Chung, Nack-Gyun ;
Choi, Bin ;
Kim, Yonggoo .
JOURNAL OF CHEMOTHERAPY, 2020, 32 (05) :251-259
[4]   Genetic and metabolic determinants of methotrexate-induced mucositis in pediatric acute lymphoblastic leukemia [J].
den Hoed, M. A. H. ;
Lopez-Lopez, E. ;
te Winkel, M. L. ;
Tissing, W. ;
de Rooij, J. D. E. ;
Gutierrez-Camino, A. ;
Garcia-Orad, A. ;
den Boer, E. ;
Pieters, R. ;
Pluijm, S. M. F. ;
de Jonge, R. ;
van den Heuvel-Eibrink, M. M. .
PHARMACOGENOMICS JOURNAL, 2015, 15 (03) :248-254
[5]   Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia [J].
Esmaili, Mohammad Ali ;
Kazemi, Ahmad ;
Faranoush, Mohammad ;
Mellstedt, Hakan ;
Zaker, Farhad ;
Safa, Majid ;
Mehrvar, Narjes ;
Rezvany, Mohammad Reza .
IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 23 (06) :800-809
[6]   Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia [J].
Gervasini, Guillermo ;
Mota-Zamorano, Sonia .
CURRENT DRUG METABOLISM, 2019, 20 (04) :313-330
[7]   Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia [J].
Gervasini, Guillermo ;
de Murillo, Silvia G. ;
Jimenez, Mercedes ;
de la Maya, Maria D. ;
Vagace, Jose M. .
GENE, 2017, 628 :72-77
[8]   Intrinsic and acquired resistance to methotrexate in acute leukemia [J].
Gorlick, R ;
Goker, E ;
Trippett, T ;
Waltham, M ;
Banerjee, D ;
Bertino, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1041-1048
[9]   High Dose Methotrexate Treatment in Childhood ALL: Pilot Study on the Impact of the MTHFR 677C&gt;T and 1298A&gt;C Polymorphisms on MTX-related Toxicity [J].
Haase, R. ;
Elsner, K. ;
Merkel, N. ;
Stiefel, M. ;
Mauz-Koerholz, C. ;
Kramm, C. M. ;
Koerholz, D. .
KLINISCHE PADIATRIE, 2012, 224 (03) :156-159
[10]   Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies [J].
Han, Jian ;
Liu, Lu ;
Meng, Li ;
Guo, Huan ;
Zhang, Jin ;
Han, Zhi-Qiang ;
Hong, Zhen-Ya .
FRONTIERS IN ONCOLOGY, 2021, 11